Spine Biologics Market is expected to grow at a CAGR of 6.1% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Spine Biologics Market size was valued at USD 4.1 billion in 2023 growing at a CAGR of 6.1% from 2023 to 2033.
• North America dominated the market in 2023
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global Spine Biologics Market size accounted for USD 4.1 Billion in 2023, growing at a CAGR of 6.1% from 2023 to 2033. Spine biologics refer to biological materials or substances used in spinal surgery to enhance the healing process or promote bone growth. These biologics can include bone grafts, growth factors, and other biological agents. The use of spine biologics is often aimed at improving the fusion process in spinal surgeries, such as spinal fusion procedures.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021656

The rising prevalence of spinal disorders and conditions, such as degenerative disc disease, spinal stenosis, and spinal fractures, contributes to the growing demand for spine biologics. Ongoing advancements in surgical techniques, including minimally invasive spine surgeries, have increased the adoption of spine biologics. These biologics can aid in the fusion process and improve overall surgical outcomes. The aging population is more susceptible to spinal issues, and as the global population continues to age, there is a corresponding increase in the number of individuals seeking spinal interventions, driving the spine biologics market. The development of new and improved spine biologics, such as growth factors, stem cell therapies, and synthetic bone grafts, contributes to market growth. These innovations aim to enhance the efficacy of spinal surgeries and reduce complications.

Key Players
Some of the major Spine Biologics Market players holding high market shares include Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Orthofix International N.V., RTI Surgical, Inc., SeaSpine, and Zimmer Biomet Holdings, Inc. Other players include Life Spine, Inc., Nutech, and XTANT MEDICAL

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021656

Segmental Analysis
Based on product, the Spine Biologics market is segmented into Spinal Allografts, Bone Graft Substitutes, and Cell-Based Matrix. Spinal allografts are the largest segment of the Spine Biologics market. This is due to their widespread use in a variety of spinal fusion procedures. Spinal allografts are derived from human bone and are processed to remove all cells and antigens, making them less likely to be rejected by the recipient. They are also highly osteoconductive, meaning that they can provide a scaffold for bone growth and fusion.
Based on Surgery, the Spine Biologics market is Open Spine Surgery and Minimally Invasive Spine Surgery. Minimally invasive spine surgery (MISS) is the largest segment of the Spine Biologics market based on surgery. This is due to the increasing popularity of MISS procedures over traditional open spine surgery. MISS procedures are associated with less pain, scarring, and recovery time than open surgery, and they are also less likely to result in complications.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.